Trump administration launches FTC probes for transgender care disclosure
Fox News correspondent Alexandria Hoff discusses the push to disrupt prescriptions of “gender-affirming” medications in U.S. hospitals due to policy changes regarding President Donald Trump’s “special report.”
President Donald Trump’s administration began investigating whether healthcare providers misrepresent or have not disclosed the risks of transgender procedures and care this week.
The Federal Trade Commission released its investigation on Monday, giving consumers a window through September 26th, moving forward with concerns that they were “exposed to false or unsupported claims about “gender-maintaining care” particularly related to minors.” The FTC held a workshop earlier this month to explore potential “deceptive trade practices” related to gender-related treatments.
“The FTC is trying to assess whether consumers (particularly minors) have been harmed and whether medical professionals or others are violating sections 5 and 12 of the FTC Act.
The investigation comes amid the ongoing campaign of the Trump administration Transgender care for minors, It will keep many providers away from such programs.
Trans surgery increases the risk of mental health and suicidal thoughts: a study
Protesters against gender-maintaining care for trans minors will demonstrate outside the Supreme Court in Washington, DC (AP Photo/Jose Luis Magana, File/AP Communication)
In May, the U.S. Department of Health and Human Services (HHS) published a comprehensive review of best practices for children and teens Gender discomfort. The report revealed that “serious concerns about medical interventions such as adolescent blockers, cross-sex hormones and surgery attempt to keep children and adolescents away from gender.”
The report highlighted evidence of risks associated with gender-related treatment, including irreversible infertility, sexual dysfunction, decreased bone density, adverse cognitive effects, cardiovascular disease, metabolic disorders, and metabolic disorders. Mental disorderssurgical complications and regret.
Research finds gender discomfort growing among younger adults in “increased acceptance,”
Health and Human Services (HHS) is skeptical of transgender care under the leadership of Robert F. Kennedy Jr. (Reuters/Ra Milis/Reuters)
The author also questioned the ethics surrounding medical interventions in children and teens with gender discomfort.
“HHS believes medical ethics should be at the heart of this debate,” the release said.
Team of DoctorAccording to HHS, medical ethicists and methodologists contributed to the review.
“The contributors represent a broad political perspective and were chosen for their commitment to scientific principles,” they said.
President Donald Trump’s administration has pushed back the involvement of biological men in transgender care for minors and women’s sports. (AP Photo / Evan Vucci / AP Newsroom)
New scrutiny has resulted in providers like the National Hospital of Children Washington, DC, No longer provides gender transition-related medical interventions.
Since last week, the hospital’s Gender Development Program web page has displayed messages to existing and new patients announcing changes that will take effect on August 30th.
Click here to get your Fox business on the go
“In light of increasing legal and regulatory risks to our children’s citizens, our healthcare providers, and the families we serve, we are suspending prescriptions for gender-affirming medications,” the message states. “Mental health and other support services for LGBT patients are still available. We are always welcome at Children’s National for other medical needs.”
Daniel Wallace and Melissaldi of Fox News contributed to this report